Made possible by charitable contributions from
Navigation Tip: Click on blue text that’s italicized, underlined and in bold for link to more information.
. The intent of this monthly newsletter is to feature current published articles that provide important prostate cancer information. You’ll notice a controversial article about the value of PSA screening on page one. While we respect the studies and analysis behind the article,
we encourage informed decision making specific to PSA testing
– especially for men who are at high risk for developing the disease. And
we encourage you to read
Us TOO International Guidelines for PSA‐Based Screening for Prostate Cancer
Also attached to this Hot SHEET is the second issue of
Between the Sheets
– a new advice column created by experts to help men and women with answers to questions about sexual health and intimacy challenges that can result from prostate cancer treatment.
This content is in response to results from a recent survey to support group leaders that identified intimacy and sexual health as underrepresented prostate cancer educational topics. Let us know what you think by emailing us at
There's still time to register for our next
FREE educational event and webcast on Saturday, September 29, in Englewood, NJ.
Attend in person, or watch the online webcast with live audio and video from the event on
prostate cancer topics including the impact of treatment on sexual health and intimacy, integrative medicine, advanced disease, immunotherapy, acupuncture and meditation; and learn about the most common health risks for men over 50.
Get answers to all of your questions from the experts: Dr. Mazyar Ghanaat, Dr. Tracy Scheller, Dr. Stacy Loeb, Dr. Anne Katz, and Dr. Charles G. Drake. Those attending the event in person will receive a
free aromatherapy kit
on sexual health and intimacy related to prostate cancer (while supplies last).
to register today.
Check out the
new Us TOO web page on
Sexual Heath & Intimacy
new Us TOO web page on
. Information provided on both topics can be helpful in managing potential side effects of prostate cancer treatment.
Because prostate cancer can be a couple’s disease, a woman may be subject to her own concerns in addition to those she shares with her husband/partner.
A Forum for Her
is a regular conference call series (and invitation-only Facebook group) from Us TOO which provides women with important peer-to-peer support.
Calls are free and participants are not required to share their identity with the group.
Find more information and
register to join a call
Change Together, an online resource managed by the Astellas Stakeholder Engagement team, will be presenting a
prostate cancer advocacy webinar
featuring leadership from ZERO, PHEN and Us TOO discussing advocacy initiatives that address the needs of the community. The event is on Thursday, October 11, at 11.00 am EST / 10.00 am CT.
Registration for the webinar
also provides post-event access to the recorded content.
For information on managing advanced prostate cancer, visit
My Prostate Cancer Roadmap
. Content includes symptoms of advanced prostate cancer, treatment options, disease management and the impact on patients and their loved ones.
Now through October 15, 2018, eligible men ages 40 and older may
register for free or discounted prostate-specific antigen (PSA) tests
at LabCorp locations in the United States. Cancer Treatment Centers of America® (CTCA) is partnering with the NFL Alumni Association in recognition of Prostate Cancer Awareness Month to spread the word about the importance of prostate cancer screening.
is a new website with educational content on several types of cancer, including prostate cancer. Information covers diagnosis and multiple
topics on prostate cancer
at various stages of the disease.
The GALAHAD clinical research study from Janssen Research & Development is now enrolling men in the U.S. who have
metastatic castration‐resistant prostate cancer and DNA‐repair anomalies
to participate in a clinical trial of an oral investigational medication for prostate cancer. All participants will receive daily investigational medication. To learn more about the GALAHAD study and find out if you may be eligible,
, Study Identifier: NCT02854436
We’d like to thank all participants, donors and sponsors of the 14th Annual SEA Blue Chicago Prostate Cancer Walk and Run
that took place on September 9. It was a beautiful day of building camaraderie in the community and honoring prostate cancer survivors/“warriors,” while raising awareness for the disease and funds for Us TOO. SEA Blue
donations will continue to be accepted through September 30 at
Mark your calendar and watch for details on the next
Prostate Cancer Pathways educational event and webcast in Chicago, IL, on Saturday, November 3
Pre-register for the event by contacting Terri Likowski at
Take care and let us know how we can help provide you with educational resources, support services and personal connections to others in the prostate cancer community.
All the best,
Chuck Strand, Chief Executive Officer
Jackie Konieczka, Office Manager
Terri Likowski, Program Director - Support Group Services
Tim Mix, Communications Manager
Amy Woods, Director of Development
Connect with Us TOO on Social Media: